Nanticoke Memorial Hospital received the American Heart Association/American Stroke Association’s Get With The Guidelines-Stroke Gold Plus Quality Achievement Award with Target: Stroke Honor Roll Elite.
The award recognizes the hospital’s commitment to providing appropriate stroke treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence. To receive the award, hospitals must achieve 85 percent or higher adherence to all Get With The Guidelines-Stroke achievement indicators for two or more consecutive 12-month periods and achieve 75 percent or higher compliance with five of eight Get With The Guidelines-Stroke Quality measures.
To qualify for the Target: Stroke Honor Roll Elite, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, Activase, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. If given intravenously in the first three hours after the start of stroke symptoms, Activase has been shown to reduce the effects of stroke and lessen the chance of permanent disability. Nanticoke Memorial Hospital earned this award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These quality measures are designed to help hospital teams follow up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients.
Nanticoke Memorial Hospital also met specific scientific guidelines as a primary stroke center, featuring a comprehensive system for rapid diagnosis and treatment of stroke patients admitted to the emergency department.